|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006560,
umls-concept:C0010346,
umls-concept:C0017337,
umls-concept:C0030705,
umls-concept:C0205216,
umls-concept:C0227327,
umls-concept:C0229671,
umls-concept:C0332281,
umls-concept:C0441889,
umls-concept:C1314939,
umls-concept:C1882417
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2006-9-20
|
|
pubmed:abstractText |
Serum C-reactive protein (CRP) levels influence the response to anti-tumour necrosis factor (TNF) therapies.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0269-2813
|
|
pubmed:author |
pubmed-author:BrandSS,
pubmed-author:CrispinAA,
pubmed-author:DambacherJJ,
pubmed-author:GökeBB,
pubmed-author:KonradAA,
pubmed-author:LohsePP,
pubmed-author:OchsenkühnTT,
pubmed-author:OtteJ-MJM,
pubmed-author:PfennigSS,
pubmed-author:SchachingerVV,
pubmed-author:SeidererJJ,
pubmed-author:ThalmaierDD
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1105-15
|
|
pubmed:dateRevised |
2007-7-10
|
|
pubmed:meshHeading |
pubmed-meshheading:16984505-Adult,
pubmed-meshheading:16984505-C-Reactive Protein,
pubmed-meshheading:16984505-Crohn Disease,
pubmed-meshheading:16984505-Female,
pubmed-meshheading:16984505-Humans,
pubmed-meshheading:16984505-Ileum,
pubmed-meshheading:16984505-Male,
pubmed-meshheading:16984505-Middle Aged,
pubmed-meshheading:16984505-Polymorphism, Genetic,
pubmed-meshheading:16984505-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
The +1059G/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease.
|
|
pubmed:affiliation |
Department of Medicine II - Grosshadern, University of Munich, Munich, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
